MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI)

Historical Holders from Q4 2020 to Q3 2025

Symbol
MRVI on Nasdaq
Type / Class
Equity / Class A Common Stock, par value $0.01 per share
Shares outstanding
144,919,287
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
130,650,870
Holdings value
$374,878,274
% of all portfolios
0%
Number of holders
157
Number of buys
73
Number of sells
-62
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
12 West Capital Management LP 8.2% $23,994,063 11,591,335 12 West Capital Management LP 31 Dec 2024
FELDMAN STUART 6.17% +28% $25,662,162 +$5,955,594 8,941,520 +30.2% Stuart Feldman 30 Sep 2025
BlackRock, Inc. 5.9% $24,626,187 8,580,553 BlackRock, Inc. 30 Sep 2025
VANGUARD GROUP INC 4.92% -22.7% $20,450,179 -$6,471,991 7,125,498 -24% The Vanguard Group 30 Sep 2025

Institutional Holders of MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 130,650,870 $374,878,274 +$4,441,317 $2.87 157
2025 Q2 129,598,496 $312,340,233 +$3,793,871 $2.41 147
2025 Q1 128,634,753 $283,834,872 -$82,865,013 $2.21 183
2024 Q4 140,252,887 $764,374,709 -$46,151,015 $5.45 182
2024 Q3 144,110,886 $1,197,438,577 -$27,583,377 $8.31 215
2024 Q2 147,440,029 $1,055,654,058 +$78,068,119 $7.16 198
2024 Q1 135,404,635 $1,173,684,706 +$20,317,754 $8.67 206
2023 Q4 134,894,754 $883,700,111 -$25,917,156 $6.55 221
2023 Q3 134,929,967 $1,348,336,074 +$67,043,720 $10.00 203
2023 Q2 126,856,268 $1,579,633,607 -$25,271,746 $12.43 219
2023 Q1 128,028,486 $1,792,250,091 +$17,285,470 $14.01 212
2022 Q4 126,849,451 $1,815,086,799 -$138,332,317 $14.31 204
2022 Q3 130,624,782 $3,334,853,905 -$30,836,051 $25.53 187
2022 Q2 131,159,603 $3,725,256,530 +$80,175,272 $28.41 202
2022 Q1 127,945,487 $4,513,679,113 -$18,120,700 $35.27 228
2021 Q4 128,005,395 $5,362,211,646 -$44,041,018 $41.90 218
2021 Q3 127,728,317 $6,268,584,283 +$685,121,082 $49.08 222
2021 Q2 114,346,717 $4,771,851,383 +$738,199,053 $41.73 194
2021 Q1 98,357,799 $3,505,428,822 +$130,695,469 $35.64 141
2020 Q4 97,446,629 $2,733,247,028 +$1,943,879,029 $28.05 114